Armata Pharmaceuticals Inc (ARMP)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2015 | 09-2015 | 06-2015 | 03-2015 | 12-2014 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -516 | 1,715 | -3,724 | -14,493 | 23,109 |
| Depreciation Amortization | 330 | 240 | 132 | 66 | 158 |
| Income taxes - deferred | -73 | N/A | N/A | N/A | N/A |
| Accounts receivable | -25 | 60 | 100 | 100 | -92 |
| Other Working Capital | -158 | -461 | -127 | 62 | -556 |
| Other Operating Activity | -9,339 | -9,018 | -1,348 | 11,960 | -35,191 |
| Operating Cash Flow | $-9,781 | $-7,464 | $-4,967 | $-2,305 | $-12,572 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -210 | -160 | -44 | -35 | -1,202 |
| Investing Cash Flow | $-210 | $-160 | $-44 | $-35 | $-1,202 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 12,780 | 12,780 | 12,781 | 12,384 | N/A |
| Financing Cash Flow | $12,780 | $12,780 | $12,781 | $12,384 | $N/A |
| Beginning Cash Position | 6,581 | 6,581 | 6,581 | 6,581 | 20,355 |
| End Cash Position | 9,370 | 11,737 | 14,351 | 16,625 | 6,581 |
| Net Cash Flow | $2,789 | $5,156 | $7,770 | $10,044 | $-13,774 |
| Free Cash Flow | |||||
| Operating Cash Flow | -9,781 | -7,464 | -4,967 | -2,305 | -12,572 |
| Capital Expenditure | -210 | -160 | -44 | -35 | -1,202 |
| Free Cash Flow | -9,991 | -7,624 | -5,011 | -2,340 | -13,774 |